Web Analytics

3 Latest Announced Rounds

  • $10,600,000
    Pre-Seed

    5 Investors

    Technology, Information and Internet
    Jun 6th, 2025
  • $13,702,071
    Series A

    3 Investors

    Insurance
    Jun 6th, 2025
  • $15,000,000
    Unknown

    1 Investors

    Biotechnology Research
    Jun 6th, 2025
$863.23M Raised in 46 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Brightstar Therapeutics

start up
United States - Lexington, Kentucky
  • 21/04/2023
  • Series A
  • Undisclosed Amount

Brightstar Therapeutics is a biotechnology company focused on providing innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases.

Brightstar Therapeutics is the first company to offer a long-term solution for persistent epithelial defects, and partial limbal stem cell deficiency through its advanced corneal allograft, BrightMEM.


Related People

Rajan ShuklaFounder

Rajan Shukla United States - Lexington, Kentucky

N/A